Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Contract Research
Return to: PBR Home | Contract Research & Services | Contract Research | News
Search Refinements

Contract Research News

View news from other Pharmaceutical sectors:
1-15 of 2113 results
Merck cholesterol drug reduces heart risk by 9% in study
By PBR Staff Writer
Merck’s cardiovascular treatment anacetrapib has reduced the risk of major coronary events in the REVEAL study.
Contract Research & Services > Contract Research > News
Peregrine Pharmaceuticals cuts 20% of workforce to reduce costs
By PBR Staff Writer
Peregrine Pharmaceuticals has cut down its workforce by up to 20%, as part of its efforts to decrease costs and achieve overall profitability.
Contract Research & Services > Contract Research > News
HitGen, LEO Pharma form research collaboration
HitGen has entered into a multi-target multi-year research collaboration with LEO Pharma to discover novel small molecule leads for various therapeutic targets of interest to the latter.
Contract Research & Services > Contract Research > News
Prana partners with Takeda in Parkinson’s gastrointestinal neuropathology
Prana Biotechnology has entered into a research collaboration with Takeda Pharmaceuticals International to study the potential of its investigational movement disorders compound, PBT434, to slow or prevent neurodegeneration of the gastrointestinal system.
Contract Research & Services > Contract Research > News
Erytech, Queen’s University to advance eryminase program
Erytech Pharma and the Queen’s University in Canada have entered into a research collaboration to advance the preclinical development of the former’s eryminase program specifically for the treatment of arginase-1 deficiency.
Contract Research & Services > Contract Research > News
Daiichi Sankyo, Max Planck and Lead Discovery enter into cancer research collaboration
Daiichi Sankyo, Max Planck Innovation and the Lead Discovery Center have inked an agreement offering Daiichi Sankyo with the option to receive the exclusive rights to a new lead compound for cancer treatment to be discovered and developed at the Lead Discovery Center.
Contract Research & Services > Contract Research > News
Pamplona to buy US firm Parexel International for $5bn
By PBR Staff Writer
Pamplona Capital Management has agreed to acquire US-based biopharmaceutical services provider Parexel International for around $5bn.
Contract Research & Services > Contract Research > News
AbCellera partners with Sanofi Pasteur to advance influenza vaccine research
AbCellera has partnered with Sanofi Pasteur to advance the research and development of next-generation influenza vaccines.
Contract Research & Services > Contract Research > News
Carlyle, GTCR to buy Albany Molecular Research for $922m
By PBR Staff Writer
The Carlyle Group and GTCR have agreed to acquire global contract research and manufacturing organization, Albany Molecular Research (AMRI), for around $922m.
Contract Research & Services > Contract Research > News
Thermo Fisher to buy pharmaceutical CDMO Patheon for $7.2bn
By PBR Staff Writer
Thermo Fisher Scientific has agreed to acquire Patheon, a provider of drug development and delivery solutions to the pharmaceutical and biopharma sectors, for around $7.2bn.
Contract Research & Services > Contract Research > News
Poxel’s diabetes drug Imeglimin succeeds in phase 2b study in Japan
Poxel has announced positive top line results of a Phase 2b trial of Imeglimin for type 2 diabetes treatment in Japan.
Contract Research & Services > Contract Research > News
Redx Pharma secures $1m grant for bacteria research
Redx Pharma has secured a $1m grant fromCARB-X, one of the world’s largest public-private partnerships, launched in July 2016 to speed up global antibacterial innovation and research.
Contract Research & Services > Contract Research > News
Bristol-Myers Squibb, CytomX extend cancer collaboration
By PBR Staff Writer
Bristol-Myers Squibb (BMS) is paying CytomX Therapeutics $200m upfront to add up to eight new candidates to their existing Probody therapeutics collaboration.
Contract Research & Services > Contract Research > News
Novimmune, LegoChem to collaborate on antibody drug conjugate research
Swiss biotech company Novimmune and South Korea based LegoChem Biosciences (LCB) have entered into a research collaboration to evaluate an antibody drug conjugate candidate.
Contract Research & Services > Contract Research > News
Heptares Therapeutics, University of Cambridge launch research collaboration
By PBR Staff Writer
Heptares Therapeutics has partnered with the University of Cambridge to discover molecules that modulate a cardiovascular target.
Contract Research & Services > Contract Research > News
1-15 of 2113 results